A study in rodents shows the growth of new neurons, also known as neurogenesis, lessens the severity of stroke and dramatically improves function following a stroke. The research suggests that drugs shown to promote neurogenesis in rodents could have benefits for human stroke victims and that those drugs -- which include antidepressants and mood stabilizers such as lithium -- may be suitable for study in human clinical trials.